Profilo
Samuil Umansky is the founder of Cardiff Oncology, Inc., which was founded in 1999.
He held the title of President from 1999 to 2006.
Currently, he is the President & Chief Scientific Officer at DiamiR LLC.
Posizioni attive di Samuil Umansky
| Società | Posizione | Inizio |
|---|---|---|
DiamiR LLC
 DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Presidente | - |
Precedenti posizioni note di Samuil Umansky
| Società | Posizione | Fine |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
DiamiR LLC
DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Samuil Umansky
